Tatva Chintan Pharma Chem Limited announces 30th AGM on September 25, 2026, via VC/OAVM.
Tatva Chintan Pharma Chem Limited will hold its 30th Annual General Meeting (AGM) on September 25, 2026, at 4:00 PM IST. The meeting will be conducted virtually via Video Conferencing/Other Audio Visual Means. This is a regulatory filing for the AGM notice.
This is a standard regulatory disclosure regarding the AGM schedule, which is a routine corporate event and does not have a significant immediate impact on the company's operations or stock.
The announcement is a routine regulatory filing for the upcoming Annual General Meeting and does not contain any new financial or business performance information, hence the sentiment is neutral.
Tatva Chintan Pharma Chem Limited has announced that its 30th Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 04:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
This intimation is in compliance with Regulation 30 read with Schedule III Part A Para A and Regulation 47 of the SEBI Listing Regulations, and in accordance with the Ministry of Corporate Affairs General Circular No. 20/2020 dated May 5, 2020, and subsequent circulars, including General Circular No. 03/2025 dated September 22, 2025.
The company has published advertisements in the Financial Express (English) and Vadodara Samachar (Gujarati) on August 18, 2026, to inform stakeholders about the upcoming AGM. The information regarding the AGM will also be available on the company's website at www.tatvachintan.com.
What to do with a filing like this
Tatva Chintan Pharma Chem Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tatva Chintan Pharma Chem Limited. Read the original for the full detail.